News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Urologix (ULGX) Names Fluet Interim CEO, Replacing Retiring Warren


11/21/2012 9:24:34 AM

Greg Fluet has been named interim CEO of Urologix Inc., replacing Stryker Warren Jr., who is retiring at the end of the month. Fluet has been chief operating officer of Plymouth-based Urologix (Nasdaq: ULGX), which develops technology for treating urological disorders, since July 2008. Before joining Urologix, Fluet worked at Sapient Capital Management, a Wyoming-based venture capital firm focused on medical devices.

Read at News Release
Read at RTT News


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES